Comment on: Therapy for Whipple's disease

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 4, 2008, Pages 968-969

  Bakkali, Nawal ^a   Fenollar, Florence ^a   Rolain, Jean Marc ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Failure; MICs; Tropheryma whipplei

Indexed keywords

BACTERIAL DNA; CARBAPENEM; CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; SULFADIAZINE; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENOME; BACTERIUM CULTURE; DISEASE EXACERBATION; DNA DETERMINATION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG HALF LIFE; DRUG PENETRATION; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; INTESTINE LIPODYSTROPHY; LEPROSY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TROPHERYMA WHIPPELII;

ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; SULFADIAZINE; TROPHERYMA; WHIPPLE DISEASE;

EID: 41149167207     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn035     Document Type: Note

References (6)

1. Knaapen HKA, Barrera P. Therapy for Whipple's disease. J Antimicrob Chemother 2007; 60: 457-8.
2. Schneider T, Moos V, Loddenkemper C et al. 100th anniversary of Whipple's disease: New aspects on pathogenesis and treatment of this enigmatic multisystemic infection. Lancet Infect Dis 2008, in press.
3. Levy M, Poyart C, Lamarque D et al. Whipple's disease: Acquired resistance to trimethoprim-sulfamethoxazole. Am J Gastroenterol 2000; 95: 2390-1.
4. Cannon R. Whipple's disease, genomics, and drug therapy. Lancet 2003; 361: 1916.
5. Boulos A, Rolain JM, Mallet MN et al. Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium. J Antimicrob Chemother 2005; 55: 178-81.
6. Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med 2007; 256: 55-66.